信息搜索
信息关键字:医
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·股票行情快报:祥生医疗(688358)7月27日主力资金净卖出152.67万元2023-7-27 20:10:32
·深圳市坪山区人民政府与复星医药签署战略合作协议2023-7-27 19:51:58
·乐心医疗发布限制性股票激励计划 2024年考核目标为净利润5000万元2023-7-27 17:33:40
·未名医药“子公司失控案”调解结案 核心资产北京科兴部分股权划归公司2023-7-27 10:01:29
·亚马逊发布AI医疗工具:可总结就诊情况 已在美东提供预览版2023-7-27 8:26:23
·股票行情快报:鱼跃医疗(002223)7月26日主力资金净买入4859.38万元2023-7-26 21:11:53
·正海生物:生物修复膜获得医疗器械注册申请《受理通知书》2023-7-26 16:13:34
·2023Q2持仓分析:医药持仓持续分化2023-7-26 10:31:12
·春立医疗(688236)7月25日主力资金净买入5.82万元2023-7-26 8:55:58
·我国特医食品顶层制度设计有望进一步完善2023-7-26 8:17:06
·鲁抗医药注射用头孢米诺钠通过仿制药一致性评价 有望提升企业业绩2023-7-25 21:46:55
·两部门印发中医馆服务能力提升建设标准和中医阁建设标准2023-7-25 21:10:43
·爱朋医疗(300753)7月25日主力资金净卖出181.74万元2023-7-25 18:20:04
·7月25日港通医疗(301515)龙虎榜数据:机构净买入1439.77万元2023-7-25 18:07:00
·复星医药:XH-S003胶囊获批进行临床试验2023-7-25 16:41:06
·上海长三角医药创新发展研究中心揭牌2023-7-25 12:57:01
·医药2023年中期策略:以创新破卷,以成长而立2023-7-25 12:15:32
·股票行情快报:乐心医疗(300562)7月24日主力资金净卖出41.76万元2023-7-25 0:14:51
·鲁抗医药:注射用头孢米诺钠通过仿制药一致性评价2023-7-24 17:40:45
·医药生物行业周报:续约规则正式发布,持续关注创新药2023-7-24 17:07:43

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]